40.60
price down icon1.26%   -0.52
after-market アフターアワーズ: 40.60
loading
前日終値:
$41.12
開ける:
$41.83
24時間の取引高:
1.98M
Relative Volume:
0.89
時価総額:
$8.37B
収益:
$2.09B
当期純損益:
$424.88M
株価収益率:
19.86
EPS:
2.0439
ネットキャッシュフロー:
$447.20M
1週間 パフォーマンス:
-8.87%
1か月 パフォーマンス:
-19.46%
6か月 パフォーマンス:
-10.34%
1年 パフォーマンス:
+4.37%
1日の値動き範囲:
Value
$40.54
$42.07
1週間の範囲:
Value
$40.28
$44.02
52週間の値動き範囲:
Value
$38.13
$57.81

Qiagen Nv Stock (QGEN) Company Profile

Name
名前
Qiagen Nv
Name
セクター
Healthcare (1116)
Name
電話
-
Name
住所
-
Name
職員
5,700
Name
Twitter
@QIAGEN
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
QGEN's Discussions on Twitter

Compare QGEN vs TMO, DHR, IDXX, A, WAT

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
QGEN
Qiagen Nv
40.60 8.37B 2.09B 424.88M 447.20M 2.0439
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
464.37 172.51B 44.56B 6.72B 6.29B 17.74
Diagnostics & Research icon
DHR
Danaher Corp
187.32 132.46B 24.57B 3.60B 5.26B 5.051
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
573.82 45.69B 4.30B 1.06B 1.04B 13.08
Diagnostics & Research icon
A
Agilent Technologies Inc
111.51 31.51B 7.07B 1.29B 993.00M 4.5355
Diagnostics & Research icon
WAT
Waters Corp
286.57 28.11B 3.17B 642.63M 516.49M 10.77

Qiagen Nv Stock (QGEN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-03-13 アップグレード Deutsche Bank Hold → Buy
2026-01-22 ダウングレード Deutsche Bank Buy → Hold
2025-12-11 ダウングレード Citigroup Buy → Neutral
2025-06-24 開始されました Barclays Overweight
2025-04-04 ダウングレード Redburn Atlantic Buy → Neutral
2025-02-19 ダウングレード Robert W. Baird Outperform → Neutral
2025-01-06 ダウングレード Morgan Stanley Overweight → Equal-Weight
2024-12-10 アップグレード Jefferies Hold → Buy
2024-10-17 ダウングレード HSBC Securities Buy → Hold
2024-06-27 アップグレード Wolfe Research Peer Perform → Outperform
2023-12-19 開始されました Wells Fargo Equal Weight
2023-12-13 開始されました Wolfe Research Peer Perform
2023-12-07 アップグレード Goldman Neutral → Buy
2023-09-12 開始されました Robert W. Baird Outperform
2023-05-23 アップグレード Morgan Stanley Equal-Weight → Overweight
2022-10-18 開始されました Morgan Stanley Equal-Weight
2022-01-18 アップグレード DZ Bank Hold → Buy
2021-10-15 再開されました Cowen Market Perform
2021-10-14 開始されました Redburn Buy
2021-07-14 ダウングレード Kepler Buy → Hold
2021-06-03 開始されました Goldman Neutral
2020-10-06 再開されました BofA Securities Buy
2020-09-28 アップグレード Kepler Hold → Buy
2020-08-24 アップグレード Citigroup Neutral → Buy
2020-08-20 再開されました JP Morgan Overweight
2020-08-17 アップグレード Berenberg Hold → Buy
2020-08-14 アップグレード Deutsche Bank Hold → Buy
2020-08-14 アップグレード Exane BNP Paribas Neutral → Outperform
2020-03-04 ダウングレード Berenberg Buy → Hold
2020-01-08 開始されました Wells Fargo Equal Weight
2020-01-07 開始されました Citigroup Neutral
2019-12-26 再開されました BofA/Merrill Underperform
2019-11-15 開始されました Stifel Hold
2019-11-14 アップグレード Evercore ISI In-line → Outperform
2019-11-14 アップグレード JP Morgan Underweight → Overweight
2019-11-14 アップグレード Kepler Reduce → Hold
2019-10-17 アップグレード Wolfe Research Peer Perform → Outperform
2019-10-09 ダウングレード Kepler Hold → Reduce
2019-10-08 ダウングレード Barclays Overweight → Equal Weight
2019-10-08 ダウングレード Deutsche Bank Buy → Hold
2019-10-08 ダウングレード JP Morgan Neutral → Underweight
すべてを表示

Qiagen Nv (QGEN) 最新ニュース

pulisher
Mar 14, 2026

Qiagen N.V. Stock (ISIN: NL0012169213) Faces Pressure Amid Life Sciences Slowdown - AD HOC NEWS

Mar 14, 2026
pulisher
Mar 14, 2026

Wellington Management Group LLP Lowers Stake in Qiagen N.V. $QGEN - MarketBeat

Mar 14, 2026
pulisher
Mar 14, 2026

Qiagen N.V. $QGEN Position Raised by Perbak Capital Partners LLP - MarketBeat

Mar 14, 2026
pulisher
Mar 14, 2026

Dnca Finance Acquires 39,063 Shares of Qiagen N.V. $QGEN - MarketBeat

Mar 14, 2026
pulisher
Mar 14, 2026

Deutsche Bank upgrades Qiagen NV (QGEN) - MSN

Mar 14, 2026
pulisher
Mar 13, 2026

BlackRock Reports 10.6% Capital and 11.8% Voting Stake in Qiagen - TipRanks

Mar 13, 2026
pulisher
Mar 13, 2026

PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView

Mar 13, 2026
pulisher
Mar 13, 2026

Release according to Article 40, Section 1 of the WpHG - TradingView

Mar 13, 2026
pulisher
Mar 13, 2026

Qiagen (NYSE:QGEN) Stock Rating Upgraded by Deutsche Bank Aktiengesellschaft - MarketBeat

Mar 13, 2026
pulisher
Mar 13, 2026

Today's Analyst Upgrade: Deutsche Bank Recommends Buy for QGEN | QGEN Stock News - GuruFocus

Mar 13, 2026
pulisher
Mar 13, 2026

Korea Investment CORP Sells 93,167 Shares of Qiagen N.V. $QGEN - MarketBeat

Mar 13, 2026
pulisher
Mar 13, 2026

Deutsche Bank upgrades Qiagen stock rating to buy on valuation By Investing.com - Investing.com India

Mar 13, 2026
pulisher
Mar 13, 2026

Deutsche Bank upgrades Qiagen stock rating to buy on valuation - Investing.com

Mar 13, 2026
pulisher
Mar 13, 2026

QIAGEN NV : Upgraded to Buy by Deutsche Bank - marketscreener.com

Mar 13, 2026
pulisher
Mar 13, 2026

Deutsche Bank Upgrades Qiagen NV (QGEN) to Buy - StreetInsider

Mar 13, 2026
pulisher
Mar 11, 2026

Assessing Qiagen (QGEN) Valuation After Recent Share Price Weakness - Yahoo Finance

Mar 11, 2026
pulisher
Mar 11, 2026

BlackRock Builds Significant Stake in Qiagen with Over 11% of Voting Rights - TipRanks

Mar 11, 2026
pulisher
Mar 11, 2026

Qiagen (NYSE:QGEN) Downgraded by Zacks Research to Strong Sell - MarketBeat

Mar 11, 2026
pulisher
Mar 11, 2026

Jefferies Financial Group Inc. Makes New Investment in Qiagen N.V. $QGEN - MarketBeat

Mar 11, 2026
pulisher
Mar 11, 2026

Capital Group Private Client Services Inc. Reduces Stock Position in Qiagen N.V. $QGEN - MarketBeat

Mar 11, 2026
pulisher
Mar 11, 2026

Qiagen gains after guidance raise - MSN

Mar 11, 2026
pulisher
Mar 10, 2026

QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndro - pharmiweb.com

Mar 10, 2026
pulisher
Mar 10, 2026

Why is Qiagen (QGEN) down 9.4% since last earnings report? - MSN

Mar 10, 2026
pulisher
Mar 10, 2026

Natixis Advisors LLC Increases Stock Position in Qiagen N.V. $QGEN - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

Qiagen N.V. (NYSE:QGEN) Given Average Recommendation of "Hold" by Analysts - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

Molecular Diagnostics Market Outlook: Set to Grow at 10%+ CAGR Through 2031 as Precision Medicine and Genetic Testing Advance, Says Mordor Intelligence - GlobeNewswire Inc.

Mar 10, 2026
pulisher
Mar 10, 2026

Qiagen N.V. $QGEN Shares Acquired by Barclays PLC - MarketBeat

Mar 10, 2026
pulisher
Mar 09, 2026

Qiagen at Leerink Global Healthcare Conference: Strategic Growth and Challenges - Investing.com India

Mar 09, 2026
pulisher
Mar 06, 2026

CEO Change: Is Qiagen NV exposed to political risk2025 Growth vs Value & Consistent Profit Trade Alerts - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Why Is Qiagen (QGEN) Down 9.4% Since Last Earnings Report? - Yahoo Finance

Mar 06, 2026
pulisher
Mar 06, 2026

Victory Capital Management Inc. Decreases Stock Position in Qiagen N.V. $QGEN - MarketBeat

Mar 06, 2026
pulisher
Mar 05, 2026

Did Qiagen’s Strategic Review Signal A Sale, Or Just A SHIFT Toward Capital Returns? - Smartkarma

Mar 05, 2026
pulisher
Mar 05, 2026

Segall Bryant & Hamill LLC Lowers Position in Qiagen N.V. $QGEN - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

BlackRock Lifts Stake in Qiagen to Over 10% of Capital - The Globe and Mail

Mar 05, 2026
pulisher
Mar 04, 2026

Qiagen Reports Restricted Stock Unit Grant to Supervisory Board Member - The Globe and Mail

Mar 04, 2026
pulisher
Mar 04, 2026

Qiagen discloses RSU vesting and share settlement for board member Eva Pisa - The Globe and Mail

Mar 04, 2026
pulisher
Mar 04, 2026

QIAGEN Updates Total Voting Rights to 206.8 Million - TipRanks

Mar 04, 2026
pulisher
Mar 04, 2026

BlackRock Discloses 11.56% Voting Stake in QIAGEN - TipRanks

Mar 04, 2026
pulisher
Mar 04, 2026

PTA-NVR: QIAGEN N.V.: Total Voting Rights Announcement according to Article 41 of the WpHG - TradingView

Mar 04, 2026
pulisher
Mar 04, 2026

Total Voting Rights Announcement according to Article 41 of the WpHG - TradingView

Mar 04, 2026
pulisher
Mar 04, 2026

Qiagen N.V. (NYSE:QGEN) Sees Significant Growth in Short Interest - MarketBeat

Mar 04, 2026
pulisher
Mar 03, 2026

Qiagen Discloses Executive Equity Award Vesting Under Long-Term Incentive Plan - TipRanks

Mar 03, 2026
pulisher
Mar 03, 2026

Qiagen Reports Grant of Restricted Stock Units to Board Member - TipRanks

Mar 03, 2026
pulisher
Mar 03, 2026

Qiagen Grants Performance Stock Units to Managing Board Member - TipRanks

Mar 03, 2026
pulisher
Mar 03, 2026

QIAGEN Reports Supervisory Board Member’s Restricted Stock Unit Release - TipRanks

Mar 03, 2026
pulisher
Mar 03, 2026

Qiagen Discloses Manager’s Restricted Stock Unit Vesting and Share Settlement - TipRanks

Mar 03, 2026
pulisher
Mar 03, 2026

QIAGEN reports executive equity award vesting under MAR disclosure rules - TipRanks

Mar 03, 2026
pulisher
Mar 03, 2026

Qiagen Discloses Supervisory Board Member’s Restricted Stock Unit Settlement - TipRanks

Mar 03, 2026
pulisher
Mar 03, 2026

PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView

Mar 03, 2026
pulisher
Mar 03, 2026

Managers' transactions announcement according to article 19 MAR - TradingView

Mar 03, 2026
pulisher
Mar 03, 2026

Qiagen (QGEN) Shares Cross Below 200 DMA - Nasdaq

Mar 03, 2026

Qiagen Nv (QGEN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
diagnostics_research LH
$263.80
price up icon 0.34%
diagnostics_research DGX
$199.70
price down icon 0.59%
diagnostics_research MTD
$1,173.74
price up icon 0.49%
$187.85
price down icon 1.29%
diagnostics_research IQV
$164.72
price up icon 1.10%
diagnostics_research WAT
$286.57
price up icon 1.15%
大文字化:     |  ボリューム (24 時間):